PIK3C3 and melanoma: Noman et al. demonstrated that genetic suppression of PIK3C3 or treatment with selective inhibitors of its kinase activity in melanoma and colorectal tumor cells could reprogram tumors from cold to warm inflamed tumors infiltrated by the immune system [24].